EDUCATION:
Sackler School of Medicine
Te-Aviv, Israel 1984-1987 M.D.
June 1987: Graduated with Excellence
PROFESSIONAL EXPERIENCE:
Aug 1993- Jan 1995 Associate in nephrology Group Practice
Dalton, Georgia
Jan 1995- Present Vainer & Vainer Nephrology
Consultants
Atlanta, Georgia
Jan 1993- Present Georgia Baptist Staff
Georgia Baptist Hospital
Atlanta, Georgia
May 1995- Present Co-Medical Director
Peachtree Dialysis Center
May 1995- Present Co-Medical Director
North Fulton Dialysis Center
Roswell, Georgia
Atlanta, Georgia
Feb 2000- Present Co-Medical Director
Cumming Dialysis Center
Cumming, Georgia
March 2000- Present Co-Medical Director
Union County Dialysis Center
Blairsville, Georgia
July 2002- Present Medical Director
Davita/Newman, Davita/Gainsville
Davita/Woodstock, Davita/Ellijay
AFFILATED HOSPITALS: Northside Hospital
North Fulton Medical Center
Saint joseph Hospital
Dunwoody Medical Center
Baptist North Hospital
TRAINING:
July 1991- June 1993 Nephrology Fellowship: Toronto General,
Wellesley Hospital and University Toronto
Toronto, Ont., Canada
July 1988- June 1991 Resident in Internal Medicine:
Maimonides
Medical Center, Affilated with Down State
Medical Center State University of N.Y.
July 1987- June 1988 Rotating Internship: (Medicine, Surgery,
Emergency Medicine,Pediatric,Radilogy
and Hematology). The Edith Wolfsen Medical
Center, Sackler School of Med.,
Tel-Aviv, Israel, Mt.Sinai Hospital, N.Y.
Summer 1986 Physician
Assistant: Outpatient Medical
Clinic, Out Patient Clinic of Internal
Medicine, Ramat Gan, Israel
RESEARCH PARTICIPATION:
Predictor of Normal Coronaries at
Angiography Division of Cardiology,
Maimonides
Medical Center.
CLINICAL RESEARCH STUDIES:
AMPS II-Principal Investigator- Using Aranesp versus thier current Procrit Therapy
- Trial designed to evaluate patients' preference for once manthly dosing. Accepted at N.K.F.,2005
Nabi- Staph Vaccine- Jan 2004- July 2005 P. Investigator.
T.R.E.A.T.- Principal Investigator - Study is design to reduce Cardiovascular events with Aranesp
Therapy within patients that have Cronic Kidney Disease, Anemia and Type 2 Diabetes.
Glomerular Disease Collaborative Network - Unc-CH-Div of Nephrology Hypertension. 2004 - Present.
Feature - S.T.A.R.T - Sub Investigator - Purpose of this study is to test the effectiveness of
Fosrenol on lowering the phosphate levels in the blood.
Amegen - 20040180 Study-Sub-Investigator: An open-label, single arm study to assess the safety
of Darbepoetin Alfa Manufactured by a Serum free bioreactor technology in subject with chronic kidney disease (2005-2006)
AMI Study 62745-5 Sub-Investigator: A phase three study of safety and efficacy of Two dose regiments
of Ferumoxytol (compared with oral iron) as an Iron replacement therapy in hemodialysis patients who recieve supplemental
EPO Therapy. (2005)
CASE REPORT: EKG Changes as early Marker of Strep Miller
Myocaardial
Abscess - Presented at American College
of Physicians, New York Chapter, March 1990
Ortho - Biotech, prompt Target Aranesp Study
PRESENTATIONS:
Mineral Components of dead Sea-Ideal factors in the
Treatment of Rheumatic Disease - Abstract XVIIth
ILAR Congress of Rheumatology, September 1989.
Influence of Circumcision on the Prevalence of
U.T.I
in the First yaer of Life (M.D. Thesis) -
Presented at American College of Physicians,
National meeting, New orleans, April
APD In Paget Disease - Presented at Clinical
Research Society of Toronto, April 11, 1992.
Plasma Cytokines and Renal Osteodytrophy, XIIth
Int, Congress of Nephrology, Jerusalem, Israel 1993
MEMBER OF: American College of Physicians
American
Medical Association
Georgia Society of nephrology
American Society of Nephrology
PERSONAL INFORMATION: Married with four children
Born March 2, 1962
Bucharest, Romania.
LANGUAGES: English,Hebrew, Italian, Romanian
